These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4996213)

  • 21. Use of intravesical thiotepa in superficial bladder tumours.
    Kulkarni JN; Kamat MR; Juvekar RL
    Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
    [No Abstract]   [Full Text] [Related]  

  • 22. [Endoscopic resection in the treatment of non-invasive excreto-urinary carcinomas of the bladder 146 endoscopic resections carried out in 53 patients].
    Fournier R; Viville C
    J Urol Nephrol (Paris); 1977 Jun; 83(6):389-96. PubMed ID: 410947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical use of Thio-Tepa for tumours of the bladder.
    Oravisto KJ
    Urol Int; 1965; 20(1):23-8. PubMed ID: 4953655
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer.
    Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
    Furnari S; Lattuca C; Pavone-Macaluso M; Leone G
    Arch Ital Urol Nefrol; 1968; 41(3):187-98. PubMed ID: 4982415
    [No Abstract]   [Full Text] [Related]  

  • 26. Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.
    Gan C; Amery S; Chatterton K; Khan MS; Thomas K; O'Brien T
    J Urol; 2016 Jun; 195(6):1697-703. PubMed ID: 26845426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder.
    Arslankoz S; Kulaç İ; Ertoy Baydar D
    Balkan Med J; 2017 Sep; 34(5):464-468. PubMed ID: 28443589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two years' experience with photodynamic therapy of bladder carcinoma.
    Windahl T; Lofgren LA
    Br J Urol; 1993 Feb; 71(2):187-91. PubMed ID: 8461953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma.
    Hollister D; Coleman M
    JAMA; 1980 Nov; 244(18):2065-7. PubMed ID: 6776297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usual harmlessness of endovesical instillations of thio-tepa].
    des Roseaux M; Vacant J; Beurton D; Cukier J
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):485-7. PubMed ID: 4216647
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
    Martínez Lasierra M; Caro Cebrián C; Sanz Vélez JI; Roncalés A; Rioja Sanz C
    Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270
    [No Abstract]   [Full Text] [Related]  

  • 36. [Personal experience with thio-tepa in the treatment of papillomas and superficial carcinomas of the bladder].
    Pellet A; Djulepa J
    Ther Umsch; 1970 May; 27(5):310-3. PubMed ID: 4994886
    [No Abstract]   [Full Text] [Related]  

  • 37. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].
    Kholodnyi MD; Mindlin SS
    Vopr Onkol; 1969; 15(8):27-32. PubMed ID: 4982329
    [No Abstract]   [Full Text] [Related]  

  • 38. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 39. [Photodynamic treatment of bladder cancer. Report of 117 cases].
    Jia ZY
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):415-6, 444. PubMed ID: 1301344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Local chemotherapy of bladder epitheliomas].
    Martinez-Piñeiro JA
    Acta Oncol (Madr); 1970; 9(1):1-27. PubMed ID: 4990619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.